Steven Cohen’s BridgeBio Oncology BBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$121K Buy
+29,570
New +$230K ﹤0.01% 3606
2026
Q1
– Sell
-23,584
Closed -$295K – 4635
2025
Q4
$295K Buy
+23,584
New +$286K ﹤0.01% 3480

Other funds holding BBOT

Steven Cohen's BBOT Position: Q3 2026 in Review

Steven Cohen opened a new position in BridgeBio Oncology (BBOT) in Q3 2026: 29,570 shares worth $121K. The stake represents ﹤0.01% of the portfolio and ranks #3606 among its holdings. This is a return to the name: Steven Cohen previously reported a position in BBOT as recently as Q4 2025.

Steven Cohen first reported a position in BBOT in Q4 2025 and has held it in 2 quarters since. The position peaked at $295K in Q4 2025. 89 funds tracked by Wall St. Rank hold BBOT as of Q3 2026.

  • Steven Cohen held 29,570 shares of BridgeBio Oncology worth $121K as of Q3 2026.
  • BridgeBio Oncology was a new Steven Cohen position in Q3 2026.
  • BridgeBio Oncology made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3606 holding.
  • Steven Cohen first reported a position in BridgeBio Oncology in Q4 2025 and has held it in 2 quarters since.
  • Steven Cohen's BridgeBio Oncology position peaked at $295K in Q4 2025.
  • 89 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.